ScoreWhy is Sanofi India Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of -8.74% and Operating profit at -6.37% over the last 5 years
2
Negative results in Dec 25
- PAT(Q) At Rs 61.70 cr has Fallen at -33.4% (vs previous 4Q average)
- NET SALES(Q) At Rs 419.80 cr has Fallen at -13.1% (vs previous 4Q average)
- PBDIT(Q) Lowest at Rs 90.30 cr.
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -44.71% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Sanofi India for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Sanofi India
-45.08%
-2.17
20.60%
Sensex
-5.4%
-0.41
12.65%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-8.74%
EBIT Growth (5y)
-6.37%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.37
Sales to Capital Employed (avg)
2.17
Tax Ratio
26.53%
Dividend Payout Ratio
65.08%
Pledged Shares
0
Institutional Holding
26.86%
ROCE (avg)
116.06%
ROE (avg)
49.40%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
21
Industry P/E
32
Price to Book Value
9.95
EV to EBIT
16.50
EV to EBITDA
15.25
EV to Capital Employed
15.28
EV to Sales
4.08
PEG Ratio
NA
Dividend Yield
5.68%
ROCE (Latest)
95.33%
ROE (Latest)
44.37%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Bearish
Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-12What is not working for the Company
PAT(Q)
At Rs 61.70 cr has Fallen at -33.4% (vs previous 4Q average
NET SALES(Q)
At Rs 419.80 cr has Fallen at -13.1% (vs previous 4Q average
PBDIT(Q)
Lowest at Rs 90.30 cr.
OPERATING PROFIT TO NET SALES (Q)
Lowest at 21.51%
PBT LESS OI(Q)
Lowest at Rs 80.20 cr.
EPS(Q)
Lowest at Rs 26.83
Loading Valuation Snapshot...
Here's what is not working for Sanofi India
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 80.20 cr has Fallen at -33.2% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 120.10 CrMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 61.70 cr has Fallen at -33.4% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 92.65 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Net Sales - Quarterly
At Rs 419.80 cr has Fallen at -13.1% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 483.13 CrMOJO Watch
Near term sales trend is very negative
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Lowest at Rs 90.30 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Lowest at 21.51%
in the last five quartersMOJO Watch
Company's efficiency has deteriorated
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 80.20 cr.
in the last five quartersMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
Earnings per Share (EPS) - Quarterly
Lowest at Rs 26.83
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
